Skip to main content
Home

Dedicated to discovery

  • Company
    • About us
    • Careers
    • Events
  • Support
    • Laboratory Planning
    • Register a Product
    • Register Your Product (USA & Canada Only)
  • Contact
  • U.S.A.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 日本
  • 中国
Home
  • Products
    • PURELAB®
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 2 +
      • PURELAB® Chorus 3
      • PURELAB® flex 1
      • PURELAB® flex 2
      • PURELAB® flex 3
      • PURELAB® flex 4
      • PURELAB® flex 5
    • CENTRA®
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA®
      • MEDICA® 7/15
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE®
      • BIOPURE® 300/600
    • ELGA Full Product Range
      • PURELAB® Classic
  • Applications
    • Atomic Absorption Spectroscopy
    • Cell and Tissue Culture
    • Clinical Biochemistry
    • Electrochemistry
    • Gas Chromatography
    • General lab water requirement
    • Immunochemistry
    • Liquid Chromatography
    • Mass Spectrometry
    • Microbiology
    • Molecular Biology
    • Spectrophotometry
  • Technologies
    • Activated Carbon
    • Electrodeionization (EDI)
    • Filtration
    • Ion Exchange
    • PureSure
    • Reverse Osmosis
    • Ultraviolet
  • Impurities In Water
    • Dissolved Gases
    • Inorganic Compounds
    • Microorganisms & Bacteria
    • Organic Compounds
    • Particulates
  • Knowledge
    • Blog
    • Case Studies
    • Ultrapure water
    • Guides and White Papers
  • Where to buy
  • Contact us
Home
  • Contact us
  • Products
    • PURELAB®
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 2 +
      • PURELAB® Chorus 3
      • PURELAB® flex 1
      • PURELAB® flex 2
      • PURELAB® flex 3
      • PURELAB® flex 4
      • PURELAB® flex 5
    • CENTRA®
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA®
      • MEDICA® 7/15
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE®
      • BIOPURE® 300/600
    • ELGA Full Product Range
      • PURELAB® Classic
  • Applications
    • Atomic Absorption Spectroscopy
    • Cell and Tissue Culture
    • Clinical Biochemistry
    • Electrochemistry
    • Gas Chromatography
    • General lab water requirement
    • Immunochemistry
    • Liquid Chromatography
    • Mass Spectrometry
    • Microbiology
    • Molecular Biology
    • Spectrophotometry
  • Technologies
    • Activated Carbon
    • Electrodeionization (EDI)
    • Filtration
    • Ion Exchange
    • PureSure
    • Reverse Osmosis
    • Ultraviolet
  • Impurities In Water
    • Dissolved Gases
    • Inorganic Compounds
    • Microorganisms & Bacteria
    • Organic Compounds
    • Particulates
  • Knowledge
    • Blog
    • Case Studies
    • Ultrapure water
    • Guides and White Papers
  • Where to buy
  • Contact us
  • Company
    • About us
    • Careers
    • Events
  • Support
    • Laboratory Planning
    • Register a Product
    • Register Your Product (USA & Canada Only)
  • Contact
  • U.S.A.
  • Deutschland
  • España
  • France
  • Italia
  • Brasil
  • 日本
  • 中国
  • Privacy policy
  • Terms & Conditions
  • Global Legal Compliance
  • Patents
  • Trademarks
  • Impressum

Let's talk about lab water

  • Categories
    • Analytical Chemistry
    • Biotechnology
    • Clinical & Pharma
    • Cool Science
    • Environment & Sustainability
    • Future Science
    • Life in The Lab
    • Life Science Results
    • PURELAB Product Design
    • Science of the Future
    • Water In The Lab
    • Water Purity
  • Authors
    • ELGA Editorial Team_cloned
    • ELGA Editorial Team
    • Natasha Zarach
    • Dr Paul Whitehead
    • Dr Alison Halliday
    • John Walker
Clinical & Pharma

Is the successful treatment for HIV causing contamination of water sources?

13 Jun 2022
- by ELGA Editorial Team

Is the successful treatment for HIV causing contamination of water sources?South Africa is known to have the highest number of people living with HIV of any country globally, with an estimated at 7.9 million infected and more than 5 million receiving antiretroviral drugs (ARVs) for the treatment of AIDS. It is estimated that several tons of ARVs are prescribed each year in South Africa, causing environmental pollution, especially in scarce freshwater sources. Unchecked, this pharmaceutical waste could harm aquatic ecosystems and cause unknown health risks to living organisms.

ARVs are labelled as environmental contaminants of emerging concern (CECs), and can enter aquatic ecosystems through industrial or domestic effluent, especially from wastewater treatment plants (WWTPs), which are not designed to remove these compounds from wastewater. Researchers at the Unit for Environmental Sciences and Management at North-West University in South Africa have been investigating whether WWTPs serving densely populated areas are contributing to increased ARV concentrations in river water. Although the risks posed by environmental ARV contamination is not fully understood, there is concern that it could lead to kidney or liver damage, and the development of ARV resistance in people living with HIV who are not currently taking antiretroviral medications.

 

Sample extraction and analysis

Water samples were taken from 22 densely populated, urban river sites upstream and downstream of WWTPs in Gauteng province. The ARVs for investigation were chosen based on their mechanism of action and frequency of prescription, and included the NRTIs didanosine and zidovudine, NNRTIs efavirenz and nevirapine, and PIs lopinavir and ritonavir. Analytical reference standards (≥99 % purity) were obtained from the US Pharmacopeial Convention, European Pharmacopoeia, British Pharmacopeia, and World Health Organization, and prepared using deionised water from an ELGA water purification system. Samples were extracted by solid-phase extraction, and analysed using LC-MS. Deionized water blanks were also included to provide negative controls. Concentrations of ARVs in water from upstream of WWTPs were then compared with the downstream values.1

 

The results

Most of the ARVs were quantifiable with a high detection frequency –86 % for nevirapine, 77 % for lopinavir, and 77 % for efavirenz – with lopinavir and efavirenz being detected in the highest concentrations – 38 μg/l and 24 μg/l, respectively. The concentrations of ARVs in surface water exceeded all others reported in the available literature. Although the concentrations of CECs in river samples at five out of seven WWTPs were higher downstream than upstream, this was not statistically significant. Also, it could not be established whether the WWTPs were sources for contamination, or if there is a direct correlation between the concentrations of ARVs and the type of treatment processes used in a particular WWTP.

 

Future applications and planning

The need to monitor the presence and effects of pharmaceuticals on the environment is greater than ever, and this study highlights the potential of increased water pollution worldwide as more people consume increased quantities of pharmaceuticals. Further research is needed on the potential risks associated with ARVs – both parent compounds and metabolites – in water sources to establish acceptable values for regulatory purposes and interventions. It is also essential that newer technologies be explored to upgrade WWTPs, in order to reduce the release of CECs into receiving waters. Improving sanitation facilities for better management of human excreta can reduce the adverse health effects caused by water pollution, and pharmaceutical companies should place strict measures to ensure safe disposal of unused drugs.

 

Why Choose ELGA LabWater?

The presence of impurities in laboratory water can be a major problem in research experiments, and can seriously compromise results. ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. We believe in providing you with water purification solutions that can meet a wide range of needs and applications, backed by excellent service and support. For more information on our Type I ultrapure water systems, check out our PURELAB Quest, PURELAB Chorus 1 Complete and our PURELAB Flex models.

 

1. Horn S, Vogt T, Gerber E, et al. HIV-antiretrovirals in river water from Gauteng, South Africa: Mixed messages of wastewater inflows as source. Sci Total Environ., 2021, 1, 806(Pt 2):150346. doi: 10.1016/j.scitotenv.2021.150346. Epub 2021 Sep 21. PMID: 34601177

Quest Download

PURELAB Quest

The only purifier on the market that dispenses all 3 types of science ready water from a compact, economical and easy to use system!

             Click Here To Find Out More

 

Explore more from our blog

27 Mar 2023
How does a plant-based diet affect the mineral content of breast milk?
9 Mar 2023
Identifying antibacterial compounds in industrial hemp
27 Feb 2023
Single-cell suspensions from the human placenta
16 Jan 2023
Measuring the effects of indoor air pollution
10 Jan 2023
A novel approach to wound healing
12 Dec 2022
3D bioprinting probiotics capsules
4 Nov 2022
Wie mikrobielle Brennstoffzellen zur Lösung von zwei dringenden globalen Umweltproblemen beitragen könnten
24 Oct 2022
New ‘designer drug’ identified in e-cigarettes

Blog Categories

  • Analytical Chemistry
  • Biotechnology
  • Clinical & Pharma
  • Cool Science
  • Environment & Sustainability
  • Future Science
  • Life in The Lab
  • Life Science Results
  • PURELAB Product Design
  • Science of the Future
  • Water In The Lab
  • Water Purity
  • Enquiry
  • Get a Quote
  • Book a Demo
  • Find an Approved Partner

Enquiry

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Get a Quote

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Book a Demo

Please check this to confirm that you have read our Terms of Service and Privacy Policy.

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater US Headquarters

ELGA LabWater North America
5 Earl Ct Suite 100
Woodridge, IL 60517
USA

Tel: 630-343-5251

ELGA LabWater UK Headquarters

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Case Studies

  • Abbott Diagnostics
  • DASA Medical Diagnostics
  • NeoDIN Medical Institute
  • North Staffordshire NHS Trust
  • Olsberg Vocational College

Resources

  • Learn About Ultrapure Water
  • Guides and White Papers
  • Purification Technologies
  • Applications
  • Impurities In Water

Blogs

  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd. trading as ELGA LabWater. 2023 - All rights reserved.
ELGA is the global laboratory water brand name of Veolia.

  • Privacy policy
  • Terms & Conditions
  • Global Legal Compliance
  • Patents
  • Trademarks
  • Impressum
  • Language
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Other Veolia Sites
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia